ESR1 and breast cancer: Taken together, these observations are consistent with the notion that suppression of the Hippo effector YAP1 by RASSF1A plays an important role in RASSF1A-induced cell cycle arrest and senescence, as well as in RASSF1A-mediated suppression of ERα-driven breast cancer.